Rigshospitalet
Copenhagen, 2100, Denmark
NCT Number: NCT03974048
The objective of this study is to investigate potential early alterations in the DNA methylation profile after severe trauma and to investigate if the early marks persist.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Copenhagen, 2100, Denmark
Background: Severe trauma is an extreme physical exposure, which may have significant consequences for the patient. In addition to anatomical injury and hemodynamic compromise, severe trauma causes an immense and rapid systemic immune reaction. At the genomic level, trauma has been found to significantly increase gene expression in circulating leukocytes, and preliminary data is also emerging that trauma may even cause epigenetic (DNA methylation) alterations.
Epigenetics, including DNA methylation, have been suggested as a mediator of genetic risk and to play a significant role in subsequent non-traumatic disease. Within the field of trauma DNA methylation has only been sparsely studied, but a few studies of traumatized animals have suggested that DNA methylation alterations may occur in relation to trauma. Even though DNA methylation is highly dynamic, some marks have been found to be stable over time, and thus may have long-term consequences.
An increasing understanding of the role of epigenetics in disease development and response may pave the way for new treatment targets and modalities for multiple diseases including trauma.
Research question: Does trauma induce immediate (<4 hours) and persistent (30 days post-trauma) changes in the epigenome of peripheral blood cells, and do epigenetic changes correlate with patient recovery?
Objectives: To identify potential early alterations in the DNA methylation profile after severe trauma AND to investigate if the early marks persist.
Study design: A prospective, observational, cohort study of trauma patients admitted to RH's trauma center. The trauma cohort will be compared to a cohort of patients admitted for elective orthopedic surgery in terms of DNA methylation profile in blood cells pre-trauma/surgery, immediately post-trauma/surgery, and 30-45 days post-trauma/surgery.
DNA methylation profiles will be assessed by array technique using Illumina's MethylationEPIC Bead-Chip.
Primary outcome: Immediate (<4 hours) post-trauma DNA methylation profile in blood cells.
Secondary outcomes: Pre-trauma/surgery DNA methylation profile, change in DNA methylation from pre-trauma/surgery to immediately and 30 days post-trauma/surgery, occurrence of organ dysfunction, sepsis, septic shock, 30-day mortality, ICU admission > 24 hours, ICU length of stay (LOS), hospital LOS.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
DNA from blood samples will be isolated and analyzed for genome-wide DNA methylation patterns using the Infinium HumanMethylationEPIC BeadChip (Illumina, San Diego, CA, USA).
Time frame: Day of trauma/surgery
Immediate (< 4 hours) post-trauma DNA methylation profile in blood cells compared to the pre-surgery (baseline) and immediate post-surgery (< 4 hours) DNA methylation profile in blood cells.
Time frame: Pre-trauma/surgery
Pre-trauma (if possible to obtain from an existing biobank) DNA methylation profile in blood cells compared to pre-surgery.
Time frame: 30-45 days after trauma/surgery
Persistence of the DNA methylation profile in blood cells 30-45 days after the trauma compared to surgical patients.
Time frame: Day of trauma/surgery
Change in DNA methylation profile in blood cells from pre-trauma (if possible to obtain) to immediately post-trauma compared to surgical patients.
Time frame: 0 to 30-45 days after trauma/surgery
Change in DNA methylation profile in blood cells from immediately post-trauma to 30-45 days post-trauma compared to surgical patients.
Time frame: Day 0-45 after trauma/surgery
Association of DNA methylation changes with injury severity. This will be done by comparing the DNA methylation profiles among patient with an injury severity score (ISS) < 15 and patients with an ISS > 15.
Time frame: Day 30 after trauma/surgery
Occurrence of organ dysfunction (increase of ≥ 2 in SOFA-score)
Time frame: Day 30 after trauma/surgery
Occurrence of sepsis or septic shock
Rigshospitalet, Denmark
Other
Identification of the Epigenetic Response to Trauma - a Prospective, Observational Study
Acronym: TrauMeth
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04705480
Analgesics, Gabapentin
Charleston, West Virginia, United States
View Trial DetailsNCT04469036
Injuries, Trauma
Sacramento, California, United States
View Trial DetailsNCT03571737
Acute Musculoskeletal Disease, Acute Pain
Greenville, North Carolina, United States
View Trial DetailsNCT01895738
Injuries, Trauma
Winnipeg, Manitoba, Canada
View Trial Details